mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml, Injektionsdispersion
7680699950010
CH-69995
J07BX
08.08.
1 / 3
google
Details
- Product number
- 6999501
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- Suspension: mRNA-1345 0.10 mg/ml, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas, cholesterolum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus, trometamolum, trometamoli hydrochloridum, acidum aceticum glaciale, natrii acetas trihydricus, saccharum, aqua ad iniectabile, 1 ml corresp., natrium 0.017 mg pro dosi.
Articles (1)
mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml, Injektionsdispersion
Injektionsdispersion
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SUS
|
0.1 MGML | Substance | Wirkstoff (Principe actif) |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
0.017 MG | Substance | HBESI |
Authorization holder
Moderna Switzerland GmbH
4052 Basel
Authorization information
- Swissmedic authorization number
- 69995
- Drug name
- mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin, Injektionsdispersion
- Galenic form
- DISII
- ATC Code
- J07BX
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 17/04/2025
- Authorization expiration date
- 16/04/2030
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- mRESVIA Vaccin à ARNm contre le VRS
- Description (DE)
- mRESVIA RSV mRNA Impfstoff
- Market launch
- 15/08/2025
- Narcotic (BTM)
- No
Application methods
IMU